thioamides - CISMeF

Preferred Label : thioamides;

MeSH definition : Organic compounds containing the radical -CSNH2.;

MeSH synonym : Thioamide;

Wikipedia link : https://en.wikipedia.org/wiki/Thioamides;

Is substance : O;

Details

Origin ID

D013854;

UMLS CUI

C0039875;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Thioamide (substance) [SNOMED CT concept]
Record concept(s)
- thioamides [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((N,N'Z,N,N'E)-N,N'-(((ethane1,2diylbis(oxy))bis(2,1phenylene))bis(methanylylidene))bis(1hydrazinylmethanethioamide) [MeSH Supplementary Concept]
- (1,3-dithiol-2-ylidene)ethanethioamide [MeSH Supplementary Concept]
- (2E)-N-methyl-2-((4-oxo-4H-chromen-3-yl)methylidene)-hydrazinecarbothioamide [MeSH Supplementary Concept]
- 1H-Pyrrole-2-carbothioamide [MeSH Supplementary Concept]
- 2,4-dihydroxybenzcarbothioamide [MeSH Supplementary Concept]
- 2,5-dihydro-3-methyl-5-oxo-1H-pyrazole-1-carbothioamide [MeSH Supplementary Concept]
- 2,6-dichlorothiobenzamide [MeSH Supplementary Concept]
- 3,4-diethoxybenzthioamide [MeSH Supplementary Concept]
- 3-(2-hydroxy-5-methylphenyl)-5-pyridin-3-yl-4,5-dihydro-1H-pyrazole-1-carbothioamide [MeSH Supplementary Concept]
- 3-(3,4-dimethylphenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide [MeSH Supplementary Concept]
- 3-(4-butoxyphenyl)propyl thioamide [MeSH Supplementary Concept]
- 4'-((N-benzoyl)aminomethanocarboxy)-2,4-dihydroxybenzcarbothioamide [MeSH Supplementary Concept]
- 4,5-dihydropyrazole-1-carbothioamide [MeSH Supplementary Concept]
- 4-chlorobenzothioamide [MeSH Supplementary Concept]
- 4-methylbenzenecarbothioamide [MeSH Supplementary Concept]
- 4-methylthiobenzamide [MeSH Supplementary Concept]
- 4-methylthiobenzamide-S-oxide [MeSH Supplementary Concept]
- 5,6-dihydropyrimidine-1(2H)-carbothioamide [MeSH Supplementary Concept]
- 5-amino-N-(prop-2-en-1-yl)-1H-1,2,4-triazole-1-carbothioamide [MeSH Supplementary Concept]
- 6-cyano-2,2-dimethyl-N-methyl-2H-1-benzopyran-4-thiocarboxamide [MeSH Supplementary Concept]
- 6-methylpicolinic acid-thioamide [MeSH Supplementary Concept]
- GSK 842879A [MeSH Supplementary Concept]
- KM 03009 [MeSH Supplementary Concept]
- MCC 134 [MeSH Supplementary Concept]
- N,N'-(1,2-phenylene)bis(3,4,5-trifluorobenzothioamide) [MeSH Supplementary Concept]
- N,N'-bis(2-bromophenyl)-2,2'-thiodibenzamide [MeSH Supplementary Concept]
- N,N'-bis(2-ethylphenyl)-2,2'-thiodibenzamide [MeSH Supplementary Concept]
- N,N'-bis(2-methylphenyl)-2,2'-thiodibenzamide [MeSH Supplementary Concept]
- N-((3-hydroxy-1,5,5-trimethylcyclohexyl)methyl)-3-chlorophenylmethanethioamide [MeSH Supplementary Concept]
- N-(3,5-difluorophenyl)-2-pyridinecarbothioamide [MeSH Supplementary Concept]
- N-(3-(1H-imidazol-1-yl)propyl)-1-(3,4-dimethoxyphenyl)cyclopropanecarbothioamide [MeSH Supplementary Concept]
- N-(4'-methoxyphenyl)-3-bromothiobenzamide [MeSH Supplementary Concept]
- N-(benzo(d)thiazol-2-ylcarbamoyl)-2-methyl-4-oxoquinazoline-3(4H)-carbothioamide [MeSH Supplementary Concept]
- N-methylthiobenzamide [MeSH Supplementary Concept]
- N-methylthiobenzamide S-oxide [MeSH Supplementary Concept]
- NCT-503 [MeSH Supplementary Concept]
- NT219 compound [MeSH Supplementary Concept]
- PARP-1 inhibitor DHC-1 [MeSH Supplementary Concept]
- SPB 02229 [MeSH Supplementary Concept]
- UC-781 [MeSH Supplementary Concept]
- Y2R antagonist SF-11 [MeSH Supplementary Concept]
- alpha-ketothioamide [MeSH Supplementary Concept]
- closthioamide [MeSH Supplementary Concept]
- dichloro((2Z)-2-((4-oxo-4H-1-benzopyran-3-yl)methylene)hydrazinecarbothioamide copper complex [MeSH Supplementary Concept]
- hydrazinecarbothioamide [MeSH Supplementary Concept]
- idd 594 [MeSH Supplementary Concept]
- isoindolin-1,3-dithione [MeSH Supplementary Concept]
- kobe2602 [MeSH Supplementary Concept]
- polythioalanine [MeSH Supplementary Concept]
- pyridine-2-carbothioamide [MeSH Supplementary Concept]
- rubeanic acid [MeSH Supplementary Concept]
- sulfinemycin [MeSH Supplementary Concept]
- t-butyloxycarbonyltyrosyl-glycyl-glycyl-phenylalanyl-psi(thioamide)leucyl benzyl ester [MeSH Supplementary Concept]
- thiobenzamide [MeSH Supplementary Concept]
- thiobenzamide-S-oxide [MeSH Supplementary Concept]
- thioviridamide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Thioamide (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients